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Objective: To evaluate blood pressure (BP) in children 
with sickle cell disease (SCD).
Methods: Observational descriptive study of BP in 70 
children with SCD. BP values were classified according to the 
V Brazilian Guidelines in Arterial Hypertension. Patients 
were divided into groups according to genotype (HbSS, 
HbSC) and according to age: group I, three to four years and 
11 months; group II, five to eight years and 11 months; and 
group III, nine to 13 years and 11 months. The Student’s t 
test and ANOVA were used for statistical analyses, and the 
level of significance was set at p<0.05.
Results: Mean and standard deviation (SD) of systolic 
BP (SBP) (mmHg) were 95.9±11.45, and of diastolic BP 
(DBP), 62.6±7.78. Means according to age group were: 
group I - SBP 91.2±5.78 and DBP 61.5±7.15; group 
II - SBP 97.3±10.86 and DBP 64.4±7.89; and group III 
- SBP 100.0±9.88 and DBP 61.5±4.94. Results showed 
that 5.7% of the patients had hypertension and 8.6%, 
pre-hypertension. Mean SBP and DBP of HbSC and HbSS 
patients did not differ. 
Conclusions: Further studies should be conducted to as-
sess BP in patients with SCD and determine possible causes 
of hypertension in these patients. 
Key-words: blood pressure; hypertension; anemia, sickle 
cell; child.
RESUMO
Objetivo: Avaliar os valores da pressão arterial (PA) em 
crianças portadoras de doença falciforme (DF).
Métodos: Estudo observacional unicêntrico descritivo de 
70 crianças portadoras de DF. Os valores da PA obtidos foram 
classificados conforme as V Diretrizes Brasileiras de Hiper-
tensão Arterial. Os pacientes foram distribuídos segundo o 
genótipo em grupo HbSS e HbSC e segundo a faixa etária: 
grupo I (três anos a quatro anos e 11 meses), grupo II (cinco 
anos a oito anos e 11 meses) e grupo III (nove anos a 13 anos 
e 11 meses). Na análise estatística, aplicou-se o teste t de 
Student e a ANOVA, sendo significante p<0,05.
Resultados: A média e o desvio padrão (DP) das medidas 
da PA sistólica (PAS) (mmHg) foram 95,9±11,45 e da PA 
diastólica (PAD) 62,6±7,78. As médias da PA por faixa 
etária foram: grupo I, PAS 91,2±5,78 e PAD 61,5±7,15; 
grupo II, PAS 97,3±10,86 e PAD 64,4±7,89; e grupo III, 
PAS 100,0±9,88 e PAD 61,5±4,94. Observou-se que 5,7% 
dos pacientes apresentavam hipertensão arterial (HA) e 
8,6% eram pré-hipertensos. A média dos valores da PAS e 
PAD entre os pacientes HbSS e HbSC não diferiu.
Conclusões: Novos estudos devem ser realizados para 
avaliar PA em pacientes com DF e detectar as possíveis causas 
de HA nesses pacientes.
Palavras-chave: pressão arterial; hipertensão; anemia 
falciforme; criança.
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RESUMEN
Objetivo: Evaluar los valores de la presión arterial (PA) 
en niños portadores de enfermedad falciforme (EF).
Métodos: Estudio observacional unicéntrico descriptivo 
de PA de 70 niños portadores de EF acompañadas en el am-
bulatorio de Hematología Pediátrica. Los valores de la PA 
obtenidos fueron clasificados conforme a las V Directrices 
Brasileñas de Hipertensión Arterial. Los pacientes fueron 
distribuidos según el genotipo en grupo HbSS y HbSC, y 
según la franja de edad: grupo I (tres años a cuatro años y 11 
meses), grupo II (cinco años a ocho años y 11 meses) y grupo 
III (nueve años a 13 años y 11 meses).
Resultados: El promedio y la desviación estándar (DE) 
de las medidas de la PA sistólica (PAS) (mmHg) fueron 
95,9±11,45 y de la PA diastólica (PAD) 62,6±7,78. Los 
promedios de la PA por franja de edad fueron: grupo I, PAS 
91,2±5,78 y PAD 61,5±7,15; grupo II, PAS 97,3±10,86 
y PAD 64,4±7,89; y grupo III, PAS 100,0±9,88 y PAD 
61,5±4,94. Se observó que el 5,7% de los pacientes presen-
taban hipertensión arterial (HA) y el 8,6% eran pre-hiper-
tensos. El promedio de los valores de la PAS y PAD entre 
los pacientes HbSS y HbSC no difirió significativamente. 
En el análisis estadístico, se aplicó la prueba t de Student y 
ANOVA, siendo significante p<0,05.
Conclusiones: La detección de HA en niños confirma la 
importancia de verificar la PA en la rutina pediátrica. Nuevos 
estudios deben realizarse para evaluar la PA en pacientes con 
EF y detectar las posibles causas de HA en esos pacientes.
Palabras clave: presión arterial; hipertensión; anemia 
falciforme; niño.
Introduction
Sickle cell disease (SCD), the most frequent hematological 
disease in Brazil, affects an important portion of the population 
in different countries. Brazilian authors estimate 3,500 new 
cases per year(1,2). The HbS gene may combine with other heredi-
tary hemoglobin anomalies, such as hemoglobin C, hemoglobin 
D and β-thalassemia, and generate combinations that are also 
symptomatic, called hemoglobinopathy SC, hemoglobinopa-
thy SD and S/β-thalassemia. All these symptomatic forms of 
expression of the HbS gene are known as SCD.
The epidemiological features, clinical signs and symptoms 
and hematological characteristics of SCD vary according to 
genotype, and the HbSS genotype is the most severe form of 
the disease. It leads to numerous complications, such as acute 
vaso-occlusive events and chronic disease, which may affect 
almost all organs and systems and result in high morbidity 
and a shorter life expectancy among these patients(2).
Kidney problems, common in SCD, start in childhood. 
About one third of all adolescents and young adults with SCD 
have nephropathies and renal abnormalities, such as impaired 
urinary concentration ability, defects in urinary acidification 
and potassium excretion, as well as glomerular disorders, such 
as glomerular hyperfiltration and proteinuria(3-5) Hyperten-
sion (HT), although frequent in African ethnicities, has not 
been frequently diagnosed in patients with SCD(3). Studies 
with adults with SCD showed that they had a lower incidence 
of HT and lower blood pressure (BP) values than patients 
without hemoglobinopathy S, but these findings have not 
been confirmed in pediatric populations(6-10). Gordeuk et 
al(11) found that patients with SCD have a higher risk of 
pulmonary hypertension and renal failure when their blood 
pressure was elevated.
The evaluation of BP in children and adolescents should 
be part of the clinical pediatric routine, and normative values 
for healthy children and adolescents are already available(12).
 
However, few studies have evaluated BP in children with 
SCD. This study evaluated BP in children and adolescents 
with SCD followed up in the Pediatric Hematology Depart-
ment of Escola Paulista de Medicina, Universidade Federal de 
São Paulo (EPM-Unifesp), São Paulo, Brazil, to investigate 
whether BP values are similar to those found among children 
without hemoglobinopathies and whether HT, a risk factor 
for stroke and pulmonary hypertension among patients with 
SCD, is also found in this population. Results were compared 
with BP values used in the literature for pediatric popula-
tions and evaluated according to the nutritional status of 
the patients included in this study.
Method
This observational descriptive study was conducted in the 
Outpatient Pediatric Hematology Service of EPM-Unifesp, 
São Paulo, Brazil, from March 2006 to July 2007. This 
study enrolled all patients with SCD (hemoglobinopathy 
HbSS and HbSC) aged three to 14 years, who were seen in 
the outpatient service during the study. The patients were 
distributed into groups according to genotype (HbSS and 
HbSC) and according to age: group I – three to four years 
and 11 months; group II – five to eight years and 11 months; 
and group III – nine years and 13 years and 11 months. 
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Patients were excluded if they had hemoglobinopathy HbS 
β-thalassemia, were receiving treatment with corticosteroids, 
anti-inflammatory, anticonvulsant or antihistaminic drugs, 
bronchodilators, digitalis or BP lowering agents or, at the 
time of data collection, had a fever or a sickling crisis. 
This study was approved by the Ethics in Research Com-
mittee of Unifesp under no. 0437/03. Parents or guardians 
received information about the study and provided written 
consent for participation.
BP, weight and height were measured by the same author 
(pediatric nephrologist) in the morning, and a specific form 
was used to record data. Three BP measurements were made 
for each patient at three different times, always by the same 
author, and all care was taken to minimize anxiety and fear 
of the procedures. Measurements were made using an aneroid 
sphygmomanometer (Lane, Medsafe Ltd., Cambridge, United 
Kingdom), acquired from OPAS and regularly calibrated, and 
the cuffs were size six, eight, 10 or 12 (Welch Allyn, Welch 
Allyn Inc, Skaneateles Falls, NY). BP measurements followed 
the V Brazilian Guidelines in Arterial Hypertension(12). BP 
values for the groups of patients were compared with BP values 
established in the literature and defined in the V Brazilian 
Guidelines in Arterial Hypertension(12). Systolic (SBP) and 
diastolic BP (SBP and DBP) were defined as normal when 
below the value of the 90th percentile for age, sex and height 
percentile, as long as below 120/80mmHg. The borderline 
value was defined as BP equal to or greater than the 90th per-
centile and below the 95th percentile for age, sex and height 
percentile; for adolescents, any value equal to or greater than 
120/80mmHg was classified as borderline, even if below the 
95th percentile for age, sex and height percentile. HT was 
defined as BP equal to or greater than the 95th percentile for 
age, sex and height percentile(12).
A digital platform scale (Filizola,, Filizola S.A., São Paulo, 
Brazil) was used to measure weight, and a wooden verti-
cal stadiometer was used for height; the horizontal rod was 
adjusted to rest on the top of the head at a right angle with 
the vertical ruler. Anthropometric measurements were made 
with the patient barefooted and wearing as little clothing as 
possible. Anthropometric data and the nutritional status were 
analyzed using the Epi-Info 6.04b software, Microsoft® Ex-
cel, and the WHO Anthro 2006(13) and Anthro Plus 2007(14). 
The anthropometric indices used to evaluate nutritional status 
were weight/age (W/A), height/age (H/A) and weight/height 
(W/H) expressed as Z scores. Nutritional status according 
to BMI was classified using the growth charts issued by the 
World Health Organization (WHO).
Quantitative variables were described as central tendency 
measures and compared using the Student’s t test. ANOVA 
was used to compare the variables between the different age 
groups. The level of significance was set at 5% (p<0.05) for 
all tests.
Results
This study included 70 patients (35 girls, 50%) aged three 
years and two months to 14 years (mean[SD] = 7.2±3.2; 
median = 6.1 years). Genotype was HbSS for 44 (63%) 
patients and HbSC for 26 (37%).
Mean (mmHg) values and standard deviations for SBP and 
DBP were 95.9±11.4 and 62.6±7.7. In the groups of patients 
with genotypes HbSS and HbSC, SBP was 97.7±10.1 and 
Table 1 - Anthropometric data of patients with sickle cell disease according to age group
 Group I (n=24) Group II (n=27) Group III (n=19) p-value
Height (cm)
mean 103.6±5.5 120.4±8.5 138.8±7.7 <0.001
Percentile 60.0±24.6 36.1±27.2 20.8±22.5 <0.001
H/A Z score 0.24±1.29 -0.22±0.74 -1.41±1.05 <0.001
Weight (kg)
mean 16.4±2.3 22.8±3.9 30.8±7.0 <0.001
Percentile 52.7±29.0 45.1±22.9 13.2±18.4 <0.001
W/A Z score 0.04±0.92 -0.12±0.70 -1.68±1.29 <0.001
W/H Z score -0.31±0.96 0.11±0.47 – <0.001
BMI
mean 15.5±1.3 15.7±1.3 15.8±11.9 0.227
BMI Z score -0.42±1.29 -0.01±0.74 -1.09±1.04 0.012
H/A: height/age; W/A: weight/age; BMI: body mass index
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93.0±8.4 (p=0.060) and DBP was 62.4±7.1 and 62.53±8.7 
(p=0.460).
The anthropometric and nutritional status deteriorated 
significantly with age (Table 1). Protein-energy malnutrition 
(PEM) was found in five patients (7.14%), two in group I and 
three in group III. The risk of PEM was found in 12 (17,1%) 
patients, five in group I and seven in group III.
SBP, but not DBP, became significantly higher with age 
(Table 2). 
HT was confirmed in four (5.71%) of the patients, two 
in group I (one HbSC and one HbSS) and two in group II 
(both HbSS), but there were no differences between sexes. 
Borderline BP was found in six (8.6%) patients, one (HbSC) 
in group I and five in group II (four HbSS and one HbSC); 
all five patients were boys. The anthropometric profile of the 
four patients with HT and the six with borderline BP did not 
differ significantly from the profile of the other patients.
SBP and DBP in the group of patients with malnutrition 
and risk of malnutrition were not significantly different 
from BP values in the group of patients with normal weight 
(Tables 3 and 4).
Discussion
BP increases progressively with age: SBP is below 
100mmHg in children younger than six years and reaches 
120/80mmHg in adulthood. Considered optimal(12), such 
variation may be understood as a physiological adaptation to 
physical development. In children, BP changes progressively 
with age, and studies demonstrated that, for that to occur, 
there must also be an increase in weight and height(15,16).
 Anthropometric results in this study are similar to 
those found in the literature and describe that patients 
with SCD may have, starting at two years of age, a body 
Table 4 - Mean diastolic blood pressure of patients with sickle cell disease according to nutritional status and age group
Normal weight n PEM risk n p-value
Group 1 61.2±7.3 20 60.4±5.4 04 0.345
Group II 64.4±7.8 22 - 02 NA
Group III 61.5±5.1 09 63.7±4.4 10 0.463
NA: not analyzed; PEM: protein-energy malnutrition
Table 2 - Systolic blood pressure and diastolic blood pressure of patients with sickle cell disease according to age group
Parameter Group I (n=24) Group II (n=27) Group III (n=19) p-value
SBP (mmHg)
Mean±SD 91.2±5.8 97.3±10.9 100.0±9.9 0.006
Median 90 98 100
Q1 88 90 90
Q3 94 104 108
DBP (mmHg)
Mean±SD 61.5±7.1 64.4±7.9 61.5±4.9 0.229
Median 60 63 60
Q1 56 60 58
Q3 66 70 64
SBP: systolic blood pressure; DBP: diastolic blood pressure; SD: standard deviation; Q1: 1st quartile; Q3: 3rd quartile
Table 3 - Mean systolic blood pressure of patients with sickle cell disease according to nutritional status and age group
Normal weight n Risk of PEM n p-value
Group 1 91.1±5.8 20 90.4±3.2 04 0.283
Group II 97.3±10.8 22 - 02 NA
Group III 99.3±10.0 09 100.1±7.8 10 0.386
NA: not analyzed; PEM: protein-energy malnutrition
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growth delay that affects weight more than height and 
accentuates progressively up to 18 years of age(17). Mean 
SBP and DBP in our study are similar to those found in 
studies with healthy children conducted by Brandão(18), 
Moura et al(19), and Sarni et al(20).
Martorell et al(21) evaluated BP in children without any 
hemoglobinopathies and reported that those with PEM had 
BP lower than normal-weight children, but our study did 
not confirm it. The number of patients with PEM in our 
sample was small, which reduces analytical power. Several 
studies(6-10) with adults found that SCD is associated with 
lower BP values and lower incidence of HT than among 
the general population, which may be a beneficial factor, 
because HT is a risk factor for sickling crises, pulmonary 
hypertension and strokes(11).
This study found that BP was abnormal (hypertension 
and pre-hypertension) in 14.3% of the patients, in agree-
ment with findings reported by Becton et al(5) in a study 
with 90 patients with SCD and ages ranging from two to 
18 years. The detection of 5.7% of the patients with HT is 
also similar to findings reported in studies conducted with 
adults and children with SCD, as well as the values found 
in the Brazilian and international literature for healthy chil-
dren and adolescents(4,17,19,22). In the study conducted by  10 
patients (11.1%) had hypertension, and four of them also 
had microalbuminuria.
The identification of patients with pre-hypertension 
should be seen as a warning sign because there is greater 
risk of progressing into HT(23), which occurred in 8.6% of 
the cases in the sample under evaluation in our study. Bec-
ton et al(5) also found a similar percentage (6.2%), and one 
of their patients had microalbuminuria.
Studies with children have found an association between 
HT and BMI(23-25). We did not confirm such association, 
probably because BMI was normal and unaltered in all 
groups. However, other factors may explain those findings: 
patients with SCD have changes in plasma renin, endothe-
lin and nitric oxide metabolites because of vaso-occlusion, 
and those changes affect the balance between vasodilatation 
and vasoconstriction, which is not seen in undernourished 
children(26-28).
Findings of HT in children with SCD stress the importance 
of measuring BP. Patients with BP above mean values are also 
exposed to greater risks of vaso-occlusive crises and death.
Mean SBP and DBP in our study were similar to those 
found in studies with healthy children without any hemoglo-
binopathies. The identification of abnormal BP (hyperten-
sion and pre-hypertension) in patients with SCD confirms the 
importance of routine BP measurements in pediatric routine. 
Multi-center studies should be conducted to evaluate BP in 
children and adolescents with SCD and detect possible causes 
of hypertension among these patients.
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